Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 77 of 297
- RecruitingPhase 2
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Crystalys Therapeutics
- Location
- Birmingham, AL + 40 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Quoin Pharmaceuticals
- Location
- Fremont, CA + 3 other US sites
- Eligibility basics
- Ages 4+
- RecruitingPhase 1
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Janssen Research & Development, LLC
- Location
- Garden Grove, CA + 7 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
PleoPharma, Inc.
- Location
- Little Rock, AR + 21 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
ViiV Healthcare
- Location
- Phoenix, AZ + 36 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
Agios Pharmaceuticals, Inc.
- Location
- Indianapolis, IN + 2 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Novo Nordisk A/S
- Location
- Lancaster, CA + 32 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Regeneron Pharmaceuticals
- Location
- Deerfield Beach, FL
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Bentonville, AR + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Novo Nordisk A/S
- Location
- Anniston, AL + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
AstraZeneca
- Location
- Fairhope, AL + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
NewAmsterdam Pharma
- Location
- Nashville, TN
- Eligibility basics
- Ages 55–85
- RecruitingPhase 2
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
Mercator MedSystems, Inc.
- Location
- Scottsdale, AZ + 17 other US sites
- Eligibility basics
- Ages 18–89
- RecruitingPhase 2/Phase 3
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Janssen Research & Development, LLC
- Location
- Centennial, CO + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels
Vifor Pharma, Inc.
- Location
- Aurora, CO + 9 other US sites
- Eligibility basics
- Ages 0 mo–11
- RecruitingPhase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Intra-Cellular Therapies, Inc.
- Location
- Huntsville, AL + 19 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- La Jolla, CA + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 2–17
- Recruiting
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
C. R. Bard
- Location
- Scottsdale, AZ + 32 other US sites
- Eligibility basics
- Ages 22–70 · Women only
- Recruiting
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Laplace Interventional, Inc
- Location
- Tucson, AZ + 9 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.
- Location
- Phoenix, AZ + 46 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Takeda
- Location
- Murrieta, CA + 23 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
INHANCE Stemless Reverse Shoulder IDE
DePuy Orthopaedics
- Location
- Atlantis, FL + 13 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Intra-Cellular Therapies, Inc.
- Location
- Dothan, AL + 33 other US sites
- Eligibility basics
- Ages 10–17
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies